Adcetris (brentuximab vedotin)

pCPA File Number: 21110
Negotiation Status:
Negotiations were not pursued
Indication(s):
Hodgkin's Lymphoma
Sponsor/Manufacturer:
Seattle Genetics Inc.
CDA-AMC Project Number:
PC0145-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: